GLI1 and breast cancer: Nevertheless, in spite of the lack of cytotoxic action, the interesting observation about the effect of the combination of Gli with doxorubicin on proliferation warrants an exhaustive research to elucidate the pathways involved in this interaction, leading to the consideration of a novel role for Gli as an adjuvant in breast cancer treatment.